MX2007003865A - Métodos para el diagnóstico temprano de infecciones virales y enfermedades inflamatorias o de la predisposición de un individuo a desórdenes proliferativos o hiperplasia. - Google Patents

Métodos para el diagnóstico temprano de infecciones virales y enfermedades inflamatorias o de la predisposición de un individuo a desórdenes proliferativos o hiperplasia.

Info

Publication number
MX2007003865A
MX2007003865A MX2007003865A MX2007003865A MX2007003865A MX 2007003865 A MX2007003865 A MX 2007003865A MX 2007003865 A MX2007003865 A MX 2007003865A MX 2007003865 A MX2007003865 A MX 2007003865A MX 2007003865 A MX2007003865 A MX 2007003865A
Authority
MX
Mexico
Prior art keywords
eag
predisposition
hyperplasia
early diagnosis
analysing
Prior art date
Application number
MX2007003865A
Other languages
English (en)
Inventor
Francisco Javier Camacho Arroyo
Walter Stuehmer
Luis A Pardo
Mike Rothe
Esther Zwick-Wallasch
Original Assignee
Ct Investig Y Estudios Del Ipn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Investig Y Estudios Del Ipn filed Critical Ct Investig Y Estudios Del Ipn
Publication of MX2007003865A publication Critical patent/MX2007003865A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

La presente invención provee un método para la identificación de la predisposición de un sujeto a un desorden proliferativo o una hiperplasia y un método para el diagnóstico temprano de una infección viral o una enfermedad inflamatoria, comprendiendo el paso de análisis del nivel de expresión de un gen para un canal de potasio eter à go-go (EAG) y10 un gen relacionado con el gen para el éter a go-go (ERG) o la actividad de un correspondiente producto de los genes en una muestra de tejido o células.
MX2007003865A 2004-10-01 2005-10-04 Métodos para el diagnóstico temprano de infecciones virales y enfermedades inflamatorias o de la predisposición de un individuo a desórdenes proliferativos o hiperplasia. MX2007003865A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04023490 2004-10-01
PCT/EP2005/010680 WO2006037611A2 (en) 2004-10-01 2005-10-04 Methods for the early diagnosis of viral infections, inflammatory diseases, a predisposition for proliferative disorders or hyperplasia by analysing eag or erg expression levels

Publications (1)

Publication Number Publication Date
MX2007003865A true MX2007003865A (es) 2009-06-17

Family

ID=35636929

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007003865A MX2007003865A (es) 2004-10-01 2005-10-04 Métodos para el diagnóstico temprano de infecciones virales y enfermedades inflamatorias o de la predisposición de un individuo a desórdenes proliferativos o hiperplasia.

Country Status (2)

Country Link
MX (1) MX2007003865A (es)
WO (1) WO2006037611A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2695101T3 (es) 2011-12-30 2019-01-02 Ventana Med Syst Inc Análisis automatizado de células tumorales circulantes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1073738E (pt) * 1998-04-21 2005-01-31 Max Planck Ges Forderung Der W Canal do iao k+ de seres humanos e as suas aplicacoes terapeuticas
AU7921200A (en) * 1999-10-20 2001-04-30 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. A new EAG gene
DE10224534A1 (de) * 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung

Also Published As

Publication number Publication date
WO2006037611A3 (en) 2006-08-03
WO2006037611A2 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
CA2735578C (en) Method of identifying risk factors for alzheimer's disease comprising tomm40 gene variants
ATE406575T1 (de) Verfahren zur erkennung von medikamentenempfindlichkeit in patienten mit entzündungskrankheiten
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
PL1712639T3 (pl) Sposób diagnozowania nowotworu przez wykrywanie krążącego DNA i RNA
GB0524110D0 (en) Biomarkers and methods for identification of agents useful in the treatment of affective disorders
WO2001040517A3 (en) Evaluating and predicting clinical outcomes by gene expression analysis
WO2007072225A8 (en) Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
WO2005114190A3 (en) Methods of identifying biomarkers
WO2006048291A3 (en) Transcriptome microarray technology and methods of using the same
EP2560006A3 (en) Biomarkers for prostate cancer and methods using the same
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
EP4306955A3 (en) Integrated functional and molecular profiling of cells
WO2006119292A3 (en) Methods for detection of biological substances
WO2012018535A3 (en) Wellness panel
WO2005040396A3 (en) qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING
WO2006073682A3 (en) Diagnostic test
WO2008138578A3 (en) Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
WO2006059252A3 (en) Methods and fluorinated compositions for treating amyloid-related diseases
WO2008122670A3 (en) Human diabetes susceptibility tnfrsf10b gene
MX2018001697A (es) Método para la cuantificación de los miembros del filogrupo i y/o del filogrupo ii de faecalibacterium prausnitzii y el uso de los mismos como biomarcadores.
EP2503338A3 (en) CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies
WO2006060393A3 (en) Biological systems analysis
WO2005118403A3 (en) Methods for detecting gene expression in peripheral blood cells and uses thereof
NZ564923A (en) Polynucleotide marker genes and their expression, for diagnosis of endotoxemia

Legal Events

Date Code Title Description
FG Grant or registration